Application Value of Serum Neurofilament Light Protein for Disease Staging in Huntington's Disease.

Xiao-Yan LiYu-Feng BaoJuan-Juan XieBin GaoShu-Xia QianYi DongZhi-Ying Wu

Published in: Movement disorders : official journal of the Movement Disorder Society (2023)

Although sNfL levels are independent of disease stages in manifest HD, it is still an optimal indicator for predicting disease onset and has potential use as a surrogate biomarker of treatment effect in clinical trials. © 2023 International Parkinson and Movement Disorder Society.

Keyphrases

clinical trial
pet ct
protein protein